Open AccessS853 Long-term Safety of Ozanimod in Patients with Moderately to Severely Active Ulcerative Colitis (UC) and Relapsing Multiple Sclerosis (RMS) Studies
Author(s) -
David T. Rubin,
Douglas C. Wolf,
О. П. Алексеева,
L Charles,
Sonia Afsari,
AnnKatrin Petersen,
James Sheffield,
Hongjuan Li,
Diego Augusto Santos Silva,
Fred Lublin,
Bruce A. C. Cree,
Jeffrey Jerome Cohen,
Silvio Danese
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000776944.98112.1a
Subject(s) - medicine , discontinuation , adverse effect , ulcerative colitis , population , disease , environmental health